metric and biochemical parameters were obtained. The European Society of Cardiology-Systematic Coronary Risk Evaluation Score (ESC-SCORE) was used to calculate total patient cardiovascular risk. Continuous variables between groups were compared using the Student t test and Mann-Whitney U test, while categorical data were compared using the χ 2 test. Multiple linear regression was used to test the association between the severity of ED and presence of target organ damage. Results: The following parameters were significantly higher in the ED group compared to the controls: family history of coronary heart disease (43.7 vs. 26.7%, p = 0.047), ESC-SCORE (2.27 ± 1.79 vs. 1.61 ± 1.13, p = 0.012), and waist circumference (109.28 ± 10.82 vs. 106.17 ± 10.07, p = 0.047). Impaired renal function (p = 0.081), albuminuria (p = 0.545), vascular damage (p = 0.602), and diastolic function (p = 0.724) were similar in both groups. However, left ventricular hypertrophy (LVH; odds ratio 2.231, 95% CI 1.069-
Introduction
Erectile dysfunction (ED) is a clinical marker of a vascular disease in high-risk patients. Risk factors for ED include hypertension [1] , diabetes mellitus [2] , cardiovascular disease (CVD) [3] , metabolic syndrome (MS) [4] , tobacco use [5] , hyperlipidemia [6] , hypogonadism [7] , lower urinary tract symptoms [8] , and depression [9] . However, the multiethnic study of atherosclerosis (MESA) showed ED to be an independent predictor of CVD events [10] .
Left ventricular hypertrophy (LVH) is associated with increased risk of major cardiovascular events and allcause mortality; it may also be an independent predictor of morbid cardiovascular events [11] . Renal dysfunction, either defined by urine albumin excretion or estimated glomerular filtration rate (eGFR), or both, also predicts a heightened cardiovascular risk [12, 13] . All these conditions are associated with diabetes [14] , myocardial infarction [15] , hypercholesterolemia [16] , valvar stenotic and regurgitate lesions [17] , as well as African American ethnicity [18] .
The temporal relationship between subclinical CVD that may precede overt clinical CVD and target organ damage by longer than a decade, and the onset of ED remains poorly described [12] [13] [14] [15] [16] [17] . Therefore, in this study, the goal was to evaluate which parameters of target organ damage or subclinical vascular disease had the strongest relationship with ED severity.
Subjects and Methods

Study Participants
The study was conducted at the Outpatient Preventive Cardiology Clinic, Vilnius University Hospital Santaros Klinikos, Lithuania. The study population consisted of 182 Caucasian primary prevention subjects. The inclusion criteria were the presence of cardiovascular risk factors, and the ability to read and understand the study and the associated questions (Fig. 1) . Patients either married or currently in a stable relationship with a partner and who were sexually active were enrolled in this study.
Written informed consent was obtained from all participants and the protocol was approved by the Institutional Review Board. Demographic data were collected from the patients, as well as a complete medical, surgical, and psychosexual history. A detailed physical examination and biochemical tests were performed. The International Index of Erectile Function (IIEF) questionnaire was used to evaluate erectile function. Participants were assigned to either of the 2 study groups based on their IIEF scores.
Study Design
In this cross-sectional study all measurements were performed in the morning between 8: 00 and 11: 00 a.m. Participants were requested to abstain from tobacco, coffee, and food for at least 12 h. Any vasoactive medication intake was to be discontinued for at least 24 h before the study.
Height in meters, weight in kilograms, and waist circumference in centimeters were measured. Waist circumference was measured with a measuring tape at the midpoint between the bottom of the rib cage and the top of the iliac crest, in a standing position, with the subject breathing normally. The body mass index was also calculated (as kg/m 2 ). Blood pressure (BP) measurements were performed with subjects in a seated position following a 10-min resting period. Two consecutive measurements of BP and heart rate were obtained and the average of the 2 measurements was recorded.
Information about traditional cardiovascular risk factors was collected from patient anamnesis, physical examination, and medical history. Hypertension was defined as any systolic BP ≥140 mm Hg and/or diastolic BP ≥90 mm Hg, or a history of antihypertensive medication use. Current smoking was defined as any cigarette smoking during the past month. 
International Index of Erectile Function
Patients were screened for the presence of ED using the validated IIEF questionnaire. A score <21 (out of a total of 25 points) was used as a threshold value for the diagnosis of ED. At this cut-off point the test has a sensitivity of 98 and a specificity of 88% [19] . The analysis focused on 2 groups: patients with an IIEF-5 score >21 (without ED, the control group) and with an IIEF-5 score ≤21 (the ED group).
Echocardiographic Examination
Echocardiography was performed with participants lying in a supine position and turned to their left side at a 30° angle. An echocardiography machine with a 2.5-MHz transducer (GE Systems, Oslo, Norway) was used to obtain 2-dimensional guided M-Mode echocardiograms at chord level just below the mitral valves. Septal and posterior wall thickness as well as left ventricular chamber dimensions were measured following the American Society of Echocardiography (ASE) guidelines. The left ventricle mass index (LVMI) was calculated using the ASE-recommended formula: , high-density lipoprotein-cholesterol [HDL-C], and TG), C-reactive protein, as well as serum creatinine were measured using the Cobas 8,000 modular analyzer series (Roche Diagnostics, Vienna, Austria). Low-density lipoprotein-cholesterol (LDL-C) was calculated using the Friedewald formula: LDL-C = TC -HDL-C -TG/2.2. The eGFR was calculated from the serum creatinine level standardized to an isotope dilution mass spectrometry using the chronic kidney disease epidemiology collaboration equation [21] . The urine albumin to creatinine ratio (ACR) was calculated in milligrams of albumin per millimole of creatinine (mg/mmol). Kidney damage was considered present with ACR ≥3 and a decreased GFR with eGFR <60 mL/min/ Differences between the ED groups were tested using the Student t test for normally distributed variables and the Mann-Whitney U test for abnormally distributed continuous variables, while categorical data were compared using the χ 2 test. The Pearson correlation was used to associate target organ damage parameters with the IIEF score.
Forward stepwise models of linear multiple regression were used to test the association between the severity of ED and impaired renal function (eGFR <60 mL/min/1.73 m 2 ), albuminuria (ACR ≥3), diastolic dysfunction, carotid plaques, LVH, and MS as independent variables. In all tests, a p value <0.05 was statistically significant.
Multiple linear regression analysis models were used to evaluate possible independent risk factors influencing the severity of ED. The multivariate model consisted of the IIEF score as the dependent variable, and impaired renal function (eGFR <90 mL/min per 1.73 m 2 ), albuminuria (ACR ≥3), diastolic dysfunction, carotid plaques, LVH, and MS as independent variables.
Results
The mean age of the population was 47.5 ± 3.4 years. Of the 182 patients, ED was diagnosed as mild in 79 (43.4%), mild to moderate in 17 (9.3%), moderate in 3 (1.6%), and severe 1 (0.5%). Men with ED had a significantly higher cardiovascular risk and prevalence of family history of coronary heart disease than those in the control group. No significant differences were found regarding smoking, diabetes mellitus, obesity, duration of obesity, MS, or hypertension between the ED patients and controls. The baseline features of both groups are presented in Table 1 .
Values of target organ damage markers were similar in both groups except for LVH (29 [29.9%] in the ED group vs. 13 [16.0%] in the control group, p = 0.022; Table 2 ). The odds ratio for LVH was 2.231 (95% CI 1.069-4.655, p = 0.022) in the ED group.
Univariate analysis showed a significant isolated association between the IIEF score and ACR (r = The echocardiographic parameters are summarized in Table 3 . No significant difference was observed between the groups regarding diastolic dysfunction (21.0% [n = 21] in the ED group vs. 23.2% [n = 19] in the control group, p = 0.724). Only the E/E'septal ratio was significantly different between the groups (11.45 ± 3.45 in the ED group vs. 10.24 ± 3.50 in the control group, p = 0.046). When all variables were assessed concurrently for influencing ED severity, only LVH (β = 1.761, p = 0.002) and impaired renal function (β = 6.207, p = 0.0001) were identified as independent predictors (Table 4) .
Discussion
In this study, the severity of ED was associated with LVH and impaired renal function. The finding that ED was associated with ventricular hypertrophy confirmed the study of Kakkavas et al. [22] in which it was reported that ED was associated with left ventricular diastolic dysfunction, which is an early abnormality in the evolution of hypertensive LVH. Heikkilä et al. [23] found a U-shaped correlation between ED and diastolic BP, which confirms the link between ED and severity of hypertension. ED and hypertension share a common pathogenesis, namely vas- Data are presented as % (n). ED+, with erectile dysfunction; ED-, control group without erectile dysfunction; eGFR, estimated glomerular filtration rate; ACR, albumin to creatinine ratio; ABI, ankle brachial index; LVH, left ventriclular hypertrophy. Table 2 . Values of target organ damage markers according to ED cular disease, with the penile vasculature a particularly sensitive marker of systemic disease. The specific mechanism is thought to be due to increased levels of angiotensin II, which contributes to systemic hypertension and has been demonstrated in the corporal blood of hypertensive rats. Increased angiotensin II levels cause a subsequent increase in reactive oxygen species, which in turn reduces nitric oxide levels via a scavenging mechanism [24] .
It is now well known that CKD is a risk factor for CVD [25] . Endothelial dysfunction is an early marker of CVD, and it has also been reported to occur in CKD patients [26, 27] . In addition, endothelial dysfunction is a cause of ED, because nitric oxide production from the endothelium decreases in this state. Therefore, it is not surprising that ED frequently occurs in CKD patients. Furthermore, consistent with our patients (all with MS), CKD patients often suffer from metabolic diseases such as hypertension, hyperlipidemia, and impaired fasting glucose. These metabolic abnormalities also cause endothelial dysfunction and are risk factors for ED as well as CVD. Therefore, in addition to the concomitant metabolic diseases, CKD per se appears, at least in some part, to cause ED via the induction of endothelial dysfunction.
The limitations of this study were the lack of penile duplex Doppler ultrasonography, at least in patients with ED based on the IIEF. Also, testosterone serum concentrations were not measured.
Conclusions
In this study, the presence of ED was associated with chronic myocardial injury, such as hypertrophy, or impaired renal function, indicating that ED is a probable marker of CVD and the need to take preventive measures towards it. Hence, patients with ED are advised to undergo both urological and cardiovascular examinations to improve not only their sexual health, but also their overall health and survival. 
